07:00 , Aug 1, 2016 |  BioCentury  |  Emerging Company Profile

Faster than McDonald

IQuity Inc. is developing assays to diagnose autoimmune diseases as soon as symptoms appear based on differences in RNA expression of both coding and non-coding genes. The company's first test could help physicians confirm difficult...
07:00 , Jul 16, 2015 |  BC Innovations  |  Finance

Foundation in disrepair

The multiple sclerosis community will lose one of its advocates for investing in research on reversing the disease when the Myelin Repair Foundation (MRF) closes its doors next month due to lack of funding that...
07:00 , Oct 16, 2014 |  BC Innovations  |  Translation in Brief

Translational tidbits

Big drive for big data In the last month, the NIH has pledged almost $100 million for big data programs aimed at making information usable and accessible to the wider research community and to create a...
07:00 , Sep 15, 2014 |  BC Week In Review  |  Company News

Merck KGaA, Pfizer, Accelerated Cure Project autoimmune news

Merck's EMD Serono Inc. biopharmaceutical division is providing at least $1 million in funding to the non-profit for a longitudinal U.S. study focused on obtaining real-world data from multiple sclerosis patients. The Optimizing Treatment --...
02:40 , Sep 12, 2014 |  BC Extra  |  Clinical News

Serono providing funding for real-world MS study

EMD Serono Inc. is providing at least $1 million in funding to the Accelerated Cure Project (ACP) for Multiple Sclerosis for the non-profit's longitudinal U.S. study focused on obtaining real-world data from MS patients. The...
07:00 , Mar 11, 2013 |  BC Week In Review  |  Company News

GNS Healthcare, Marin Community Foundation neurology news

Orion Bionetworks, a not-for-profit alliance of public-private partners, debuted to develop predictive models to better understand brain and CNS diseases, including multiple sclerosis. GNS Healthcare also joined the alliance and will use its Reverse Engineering...
02:12 , Mar 5, 2013 |  BC Extra  |  Company News

Orion alliance debuts to develop predictive MS models

Orion Bionetworks, a not-for-profit alliance of public-private partners, debuted on Monday to develop predictive models to better understand brain and CNS diseases, including multiple sclerosis (MS). GNS Healthcare Inc. (Cambridge, Mass.) also joined the alliance...
07:00 , Apr 23, 2012 |  BC Week In Review  |  Company News

Massachusetts General Hospital autoimmune news

The hospital launched a social media website to expand the knowledge base of multiple sclerosis research and advance the development of treatments. The MS Discovery Forum website provides the MS research community with access to...